Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model

Margaret C Grabb1, Alan J Cross, William Z Potter

  • 1From the *National Institute of Mental Health, NIH, Rockville, MD; †AstraZeneca Neuroscience Innovative Medicines Unit, Cambridge, MA; and ‡UCLA Semel Institute for Neurosciences, Los Angeles, CA.

Summary

No abstract available in PubMed .

Related Concept Videos